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SUMMARY
Objective: To study the antibody prevalence against dengue in the municipality of Jun-
diaí, São Paulo, Brazil, due to the low number of official confirmed autochthonous cases. 
Methods: A serological study on dengue infection was conducted during January 2010 
and previous reports on dengue and entomological surveillance during that period were 
reviewed. Results: A prevalence of 7.8% IgG positive (68:876) was found. Furthermore, 
based on the detection of IgM antibodies in five samples, it was observed that the inci-
dence of dengue in the city at the time of the survey contrasts with the absence of noti-
fications by local health authorities over the same period of time. Conclusion: These re-
sults highlight the discrepancies between the actual and the detected number of dengue 
infections, possibly due to significant numbers of asymptomatic infections aggravated by 
difficulties with dengue clinical diagnosis. 
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RESUMO
O ônus da dengue: Jundiaí, Brasil – Janeiro 2010
Objetivo: Estudar a prevalência de anticorpos contra a dengue no município de Jundiaí, 
São Paulo, Brasil, dado o baixo número de casos confirmados autóctones.  Métodos: Foi 
realizado um inquérito sorológico durante Janeiro de 2010 e uma revisão dos reportes 
da dengue e da vigilância entomológica. Resultados: Foi encontrada uma prevalência de 
7,8% de anticorpos IgG positivos (68:876) e, com base na detecção de anticorpos IgM em 
cinco amostras, é preciso ressaltar que a incidência da dengue na cidade no momento 
da pesquisa contrasta com a ausência de notificações por parte das autoridades de saúde 
locais no mesmo período de tempo. Conclusão: Esses resultados destacam a discrepân-
cia entre o número real e o número de infecções detectadas, possivelmente devido a 
um número significativo de infecções assintomáticas, agravado por dificuldades com o 
diagnóstico clínico da doença. 
Unitermos: Dengue; epidemiologia; sorologia.
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INTRODUCTION
Dengue fever (DF) is caused by any of the four closely re-
lated flaviruses transmitted by Aedes aegypti mosquitoes 
(serotypes 1 through 4)1. Accordingly, the geographic dis-
tribution of Aedes mosquitoes globally matches the area of 
dengue transmission2. Currently, the dengue virus (DENV) 
is the most common arbovirus causing a neglected human 
disease around the world. Furthermore, the number of cases 
has increased dramatically during the past three decades in 
the Americas3. Currently, there is no available dengue vac-
cine or antiviral therapy; therefore, dengue prevention is 
based almost entirely on vector control4.
The Pan American Health Organization (PAHO) re-
ports that Brazil comprised approximately 46% of the re-
ported cases in 2009 (528,883) and 60.65% of the cases in 
2010 (1,004,392)5. Moreover, the State of São Paulo was 
among those that had the most reported cases, accord-
ing to the 2010 dengue epidemiological report from the 
Brazilian Ministry of Health6. During that year, the State 
of São Paulo accumulated 188,593 cases, a sharp increase 
(2,096%) compared to 8,996 cases reported in 2009 (Cen-
tro de Vigilância Epidemiolológica Alexandre Vranjac – 
CVE)7. Despite efforts to contain the disease, dengue keeps 
growing in most states of Brazil where the vector thrives. 
In 2010, the municipality of Jundiaí, in the state of São 
Paulo, had an estimated population of 369,7108. Dengue 
cases have been documented since 2004 by the municipal 
health authorities, and there was a peak of 51 autochtho-
nous cases in 2008. Interestingly, in 2009 only four autoch-
thonous cases were reported.
The low number of confirmed autochthonous cases in 
Jundiaí suggests that there were cases that went undetect-
ed, either by difficulties with the diagnosis or because they 
were asymptomatic (in which case patients do not show 
up for testing), or as a result of broad herd immunity in 
the human population that does not allow for the onset of 
epidemics with many symptomatic cases. To address this 
issue, a serological survey following a random sampling 
was conducted during January 2010 (when virus activity is 
expected to occur in the Southern Hemisphere) and also 
reviewed previous technical reports on dengue and ento-
mological surveillance from both the state of São Paulo 
and the city of Jundiaí.
POPULATION AND METHODS
Jundiaí is a well-developed city located in the eastern part 
of the State of São Paulo at 23º 11’ 11” S and 46º 53’ 03” W, 
at an elevation of 762 m above sea level, occupying a land 
area of 431.97 km2 within at the Atlantic rainforest biome. 
According to the state of São Paulo’s Metropolitan Planning 
Company (Empresa Paulista de Planejamento Metropoli-
tano – Emplasa), Jundiaí is composed of an agglomeration of 
municipalities (Cabramatta, Limpo Paulista, Itupeva, Jarinu, 
Jundiaí, Louveira, and Várzea Paulista) totaling 800,000 in-
habitants, located between the important urban-industrial 
centers of São Paulo and Campinas, with about 18 million 
people within a radius of 80 km. Most of the dislocations 
that occur every day are directed towards the agglomeration 
itself, with the second destination being the metropolitan 
area of São Paulo. It is noteworthy that, in health grounds, all 
municipalities in the conurbation have a heavy transit flow 
with Jundiaí. Most treatments outside the municipality of 
residence that require hospitalizations occur in health facili-
ties of Jundiaí in the following proportions: Várzea Paulista 
(91.7%), Jarinu (90.9%), Itupeva (86.8%), Limpo Pau- 
lista (86.2%), and Cabramatta (75.6%).
The approach to this dengue serological survey was to 
check the immunological status of the population of Novo 
Horizonte and São Camilo, which where the neighborhoods 
that reported most dengue cases during the 2008 outbreak 
(37 cases in Novo Horizonte and six cases in São Camilo). 
The sample size was calculated assuming a prevalence of 
0.25% and the estimated population size of the municipality, 
which means that a dengue prevalence ~ 250 times higher 
than what can be inferred from technical reports issued by 
the health authorities in Jundiaí (~ 0.01%) was considered. 
Therefore, partitioned according to the estimated popula-
tion size of each neighborhood, the experimental design en-
tailed approximately 340 samples from São Camilo and 560 
samples from Novo Horizonte, for a total expected sample 
size of 900. Households for sample collection were random-
ly selected from address records provided by the municipal-
ity. Health technicians randomly selected one resident per 
household, from which a single blood sample of 5 mL was 
collected. The ethical institutional review boards of Instituto 
de Ciências Biomédicas (ICB) - Universidade de São Paulo 
(USP) and Faculdade de Medicina de Jundiaí (FMJ) re-
viewed and approved the study. All participants volunteered 
to provide blood samples and age information for this study, 
after receiving a detailed explanation of the study and sign-
ing an informed consent. 
The serological survey was carried out using the dengue 
IgG and IgM enzyme-linked immunosorbent assay (ELISA) 
(Bioeasy), following suppliers’ recommendations. Data on 
entomological surveillance during 2009 were retrieved from 
the Superintendency of Endemic Diseases Control (Super-
intendência de Controle de Endemias – SUCEN). DENV 
technical reports were obtained from the CVE or provid-
ed by the health authorities of the municipality. A total of 
886 samples were collected from January 11 to 25, 2010 
(299 samples from São Camilo and 587 from Novo Horizon-
te). By comparing the sampling age distribution with that 
of the State of São Paulo9, it was found that both age struc-
tures were not significantly different (χ2 = 0.0046, d.f. = 7, 
p = 1.0), meaning that the sampling from Jundiaí could be 
considered a random sampling of the state population.  
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RESULTS AND DISCUSSION
ELISA was carried out for 876 serum samples, since ten 
samples from Novo Horizonte were not included due to 
technical problems. The 83 samples that were initially 
positive for IgG, were re-tested immediately after the first 
trial resulting in 68 confirmed positives (68:876) (Table 1).  
Subsequently, a serological test for dengue IgM antibodies 
was performed using the 68 IgG positive samples, result-
ing in five IgM seropositives (5:68). Remarkably, a 7.8% se-
ropositivity for IgG in the two neighborhoods under study 
was found. Assuming that the sample reflects to some ex-
tent the local population, one could extrapolate a cumula-
tive number of approximately 28,690 possible seropositive 
cases in Jundiaí. In contrast, the local authorities in Jundiaí 
reported a cumulative number of 98 autochthonous cases 
from 2004 to 2008. Likewise, a serological survey car-
ried out in the region of the US-Mexican border revealed, 
for two cities, that the prevalence of the antibody against 
dengue was of 39% to 50%, a percentage 20 times higher 
than the cumulative number of cases from 1980 to 200710. 
Discrepancies between reported dengue disease cases and 
actual level of transmission may arise due to silent trans-
mission given the high asymptomatic infection rate11. An-
other explanation foresees a scenario of re-introductions 
of viremic patients or vectors, which do not ignite large 
outbreaks. For example, five imported dengue cases were 
reported in Jundiaí during 2009, and the daily population 
commutes towards Jundiaí, indicating a strong interac-
tion between the municipalities of the conurbation. In any 
case, it can be argued that proper verification of the actual 
number of infected people is paramount in localities with 
reduced number of notified cases, especially in countries 
such as Brazil where suspected dengue cases are among 
the diseases of compulsory notification. This notification 
does not require the confirmation of diagnosis, and all 
suspected cases do not have to be reported to and further 
investigated by the public health agencies. Notably, it has 
been shown that insufficient political commitment, in-
adequate financial resources, and increased urbanization 
have contributed to the dramatic increase in dengue cases 
in the Americas and, consequently, the epidemic control 
will largely be financially dictated, whereby budgetary 
allocations should match the size of the problem3,12. Fur-
thermore, an analysis combining available information on 
reported cases, levels of underreporting, and cost per case, 
showed that Brazil is the country with highest economic 
impact of dengue, and that roughly 60% of these costs are 
due to productivity losses (indirect costs), which affect 
households, employers, and government13, highlighting a 
need for improved surveillance.
Given the disagreement between officially reported cas-
es and the estimated and predicted seroprevalence, avail-
able statewide data on the yearly number of notified dengue 
cases and the yearly-averaged mosquito infestation index-
es for Jundiaí and other 124 municipalities from 2009 was 
further analyzed. Previous studies14,15 were able to predict 
dengue transmission based on the Breteau Index (BI). The 
control of vector-borne diseases, intermediate hosts, and 
entomological surveillance performed by the SUCEN in 
the State of São Paulo is based on the BI and on a larval in-
dex (PI, which indicates the number of containers positive 
for larvae per 100 houses). Therefore, both BI and PI were 
contrasted with reported cases. Although the infestation 
indexes and number of cases showed seasonal increase in 
summer months, a simple linear regression did not show 
any significant correlation between the number of total 
dengue cases to either the annual averaged BI (r2 = 0.003) or 
PI (r2 = 0.003). In any case, it is important to highlight that 
yearly-averaged infestation indexes for Jundiaí (IP = 0.93, 
IB = 0.94) were similar to those measured for nearby cities 
that registered higher numbers of cases, such as Campinas 
(IP = 0.99, IB = 1.08, with 168 autochthonous and 22 im-
ported cases). These data, in agreement with the present 
serology data, suggests that the real number of infections in 
Jundiaí (and maybe elsewhere) may be considerably high-
er than the detected by the health authorities. The num-
bers of dengue cases (autochthonous and imported) re-
ported by the CVE, which varied quite significantly across 
the State, were also considered. As an example, in the 42 
cities within the administrative area XVII (where Jundiaí 
belongs), the number of both types of cases had a strongly 
right-skewed distribution (skewness coefficient ≈ 4.7) 
with a median of zero cases for both imported (range = 22) 
and autochthonous (range = 168) cases, with mean values 
of 9.3 ± 4.3, and 1.7 ± 0.6 respectively. Other than low 
numbers, these results evidenced a significant variation on 
the actual figures at nearby cities, which means that there 
is a great locality-specific fluctuation in reported cases for 
  São Camilo Novo Horizonte Total
ELISA Tested Positive Tested Positive Tested Positive
IgG 299 20 (6.7%*) 577 48 (8.3%) 876 68 (7.8%)
IgM 20 1 (5%) 48 4 (8.3%) 68 5 (7.3%)
*Percentages of positives from the number of samples tested, respectively; ELISA, enzyme-linked immunosorbent assay.
Table 1 – Serological results for IgG and IgM antibodies during January 2010 in two neighborhoods of Jundiaí, São Paulo, 
Brazil
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neighboring cities with similar demographic and ecologi-
cal characteristics to sustain dengue transmission.   
However, from the present data alone, it cannot be 
concluded that dengue cases must have occurred and were 
underreported in Jundiai, because the 68 seropositive in-
dividuals were not interviewed for a history of dengue-like 
illness in the past five to ten years. Consequently, it cannot 
be asserted that there is a sub-notification of cases. As an 
additional caveat, it is worth considering that the IgG neg-
ative samples were not tested for IgM. Therefore, a proper 
distinction between primary or secondary infections was 
not possible. Nevertheless, IgM antibodies are usually de-
tected during the first three months post-infections. Ad-
ditionally the present findings may also imply five recent 
infection events, which had to have occurred between No-
vember 2009 and January 2010 and could be significant for 
a sustained silent transmission of dengue.
Remarkably, the appropriate method to estimate sub-
notification would be by reviewing medical records of 
acute febrile illnesses at the primary care facilities and iden-
tifying those patients with clinical symptoms compatible 
with acute dengue fever, then addressing why dengue was 
considered. Moreover, in- and out-patient records from 
Jundiai hospitals were not analyzed for febrile syndromes 
observed during 2009-2010. Nevertheless, perhaps some 
dengue cases were diagnosed as influenza following the 
H1N1 flu pandemic. Given that dengue infection with any 
of the dengue serotypes may be asymptomatic in the ma-
jority of cases or may result in a wide spectrum of clinical 
symptoms, ranging from a flu-like fever to an incapacitat-
ing high fever, many dengue cases go undiagnosed. In ad-
dition, passive surveillance has been shown to significantly 
underestimate infection rates and is a factor constraining 
the control of dengue in the Americas12.
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